Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:36 AM
Ignite Modification Date:
2025-12-26 @ 10:36 AM
NCT ID:
NCT04158128
Eligibility Criteria:
Inclusion Criteria:
* 1\. Patients with newly diagnosed PCNSL at National Taiwan University Hospital from January 1996 to December 2020
* 2\. Patients aged 20 years and older
Exclusion Criteria:
* 1\. Subjects who are involved in any interventional treatment that might change experimental biomarkers, such as PD-L1 inhibitor, PD-1 inhibitor, anti CTLA-4 agents…etc before tumor and CSF sampling.
* 2\. Pregnancy or breast-feeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT04158128
Study Brief:
Protocol Section:
NCT04158128